Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
iShares MSCI India ETF
INDA
$6.56B
| $2.91M | ﹤0.01% |
55,300
-91,200
| -62% | -$5.02M |
|
|
PCH
1802
DELISTED
PotlatchDeltic
PCH
| $2.91M | ﹤0.01% |
74,099
-78,300
| -51% | -$3.32M |
|
1803
Dine Brands
DIN
$447M
| $2.9M | ﹤0.01% |
96,500
-158,200
| -62% | -$5.09M |
|
1804
Otter Tail
OTTR
$3.9B
| $2.9M | ﹤0.01% |
39,335
-19,975
| -34% | -$1.56M |
|
1805
Silvercrest Asset Management
SAMG
$79.6M
| $2.9M | ﹤0.01% |
157,537
-5,900
| -4% | -$105K |
|
1806
Acco Brands
ACCO
$401M
| $2.89M | ﹤0.01% |
549,700
+60,700
| +12% | +$337K |
|
1807
Entrada Therapeutics
TRDA
$290M
| $2.87M | ﹤0.01% |
166,200
+72,400
| +77% | +$1.31M |
|
1808
Republic Bancorp
RBCAA
$1.92B
| $2.87M | ﹤0.01% |
41,100
-300
| -0.7% | -$21.4K |
|
1809
Byline Bancorp
BY
$1.78B
| $2.87M | ﹤0.01% |
99,000
+40,900
| +70% | +$1.19M |
|
1810
Distribution Solutions Group
DSGR
$1.62B
| $2.87M | ﹤0.01% |
83,400
-9,145
| -10% | -$351K |
|
|
IAUX
1811
i-80 Gold Corp
IAUX
$1.45B
| $2.87M | ﹤0.01% |
5,910,533
+4,793,333
| +429% | +$3.88M |
|
1812
Enanta Pharmaceuticals
ENTA
$383M
| $2.86M | ﹤0.01% |
498,000
-26,900
| -5% | -$258K |
|
|
GRDN
1813
Guardian Pharmacy Services
GRDN
$2.43B
| $2.86M | ﹤0.01% |
+141,100
| New | +$2.91M |
|
|
CMRX
1814
DELISTED
Chimerix, Inc.
CMRX
| $2.85M | ﹤0.01% |
820,349
-518,941
| -39% | -$732K |
|
1815
InfuSystem Holdings
INFU
$244M
| $2.85M | ﹤0.01% |
337,609
+8,700
| +3% | +$68.6K |
|
1816
Airgain
AIRG
$72.2M
| $2.85M | ﹤0.01% |
404,036
+39,436
| +11% | +$345K |
|
1817
Immunocore
IMCR
$1.74B
| $2.85M | ﹤0.01% |
96,570
-179,630
| -65% | -$5.68M |
|
1818
Priority Technology Holdings
PRTH
$453M
| $2.85M | ﹤0.01% |
242,200
+194,300
| +406% | +$1.52M |
|
1819
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.95B
| $2.84M | ﹤0.01% |
152,125
-393,036
| -72% | -$7.41M |
|
1820
Erasca
ERAS
$6.43B
| $2.84M | ﹤0.01% |
1,133,000
-158,000
| -12% | -$433K |
|
1821
Liberty Live Group Series A
LLYVA
$9.66B
| $2.84M | ﹤0.01% |
+42,600
| New | +$2.64M |
|
1822
United Parks & Resorts
PRKS
$2.04B
| $2.83M | ﹤0.01% |
50,400
+41,400
| +460% | +$2.27M |
|
1823
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
| $2.83M | ﹤0.01% |
+101,600
| New | +$2.78M |
|
1824
Riley Exploration Permian
REPX
$800M
| $2.83M | ﹤0.01% |
88,615
+11,915
| +16% | +$368K |
|
|
XRN
1825
Chiron Real Estate Inc
XRN
$491M
| $2.83M | ﹤0.01% |
73,221
+8,401
| +13% | +$372K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.